Clinical Social Workers in Plainsboro, NJ Accepting Medicare
5 Clinical Social Workers found. Showing 1 - 5
 Ms. Karen Jean Kent, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 666 Plainsboro Rd, Suite 435, Plainsboro, NJ 08536 Phone: 609-716-8700 |
Miss Shela Tibaut, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 906 Hunters Glen Dr, Plainsboro, NJ 08536 Phone: 609-375-6464 |
Leslie Richmand, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 666 Plainsboro Rd Ste 1216, Suite 1216, Plainsboro, NJ 08536 Phone: 609-731-1200 |
Mrs. Paula Bonder Frost, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 503 Plainsboro Rd, 2nd Floor, Plainsboro, NJ 08536 Phone: 609-275-5747 Fax: 609-275-8228 |
Janine Averbach, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Plainsboro Rd, Center For Eating Disorders Care, Plainsboro, NJ 08536 Phone: 609-853-7588 |
News Archive
Patent-based regulation of genetic resources could undermine health in developing countries
The Australian APEC Study Centre has released a report showing how proposals for a patent-based regime to regulate access to genetic resources could inhibit efforts to protect biodiversity and undermine health in developing countries.
New approach could regenerate skull bone with better quality and no scar tissue
A team of researchers repaired a hole in a mouse's skull by regrowing "quality bone," a breakthrough that could drastically improve the care of people who suffer severe trauma to the skull or face.
Phase III study of REVLIMID for treating patients with multiple myeloma shows improvement in PFS
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
Echo total revenues increase to $447,000 for fiscal year 2011
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced financial results for the year ended December 31, 2011.
Scientists discover promising agents to fight antibiotic-resistant bacteria
In the fight against "superbugs," scientists have discovered a class of agents that can make some of the most notorious strains vulnerable to the same antibiotics that they once handily shrugged off. The report on the promising agents called metallopolymers appears in the Journal of the American Chemical Society.
› Verified 7 days ago
Pharmacists
Dentists
Occupational Therapists
Psychologists
Clinical Social Workers
Counselors